By: Dr. Marwa Badran
1. Extended IntroductionCervical cancer is one of the most preventable yet potentially fatal gynecological malignancies. It arises from the uncontrolled growth of abnormal cells in the cervix, most commonly as a consequence of persistent infection with high-risk human papillomavirus (HPV) types. Despite advances in screening and vaccination, cervical cancer remains a significant public health concern, particularly in low- and middle-income countries.Early detection through regular screening and timely intervention can dramatically reduce morbidity and mortality. Understanding the disease process, risk factors, and preventive strategies is essential for improving patient outcomes.
2. Medical DefinitionDefinition:Cervical cancer is a malignant neoplasm originating from the epithelial lining of the cervix, typically developing after a prolonged premalignant phase.Medical Term:Cervical Cancer
3. EpidemiologyFourth most common cancer among women worldwideAccounts for over 600,000 new cases annuallyResponsible for approximately 300,000 deaths per yearHighest incidence in regions with limited screening programs
4. Etiology and Risk Factors4.1 Etiological FactorsPersistent infection with high-risk HPV types (HPV 16, 18)Failure of immune clearance of HPV infection4.2 Risk FactorsEarly onset of sexual activityMultiple sexual partnersSmokingImmunosuppressionLong-term oral contraceptive useLack of regular cervical screening
5. PathophysiologyThe pathogenesis of cervical cancer follows a well-defined sequence:HPV infection of basal epithelial cellsViral oncoproteins (E6 and E7) inactivate tumor suppressor genes (p53, Rb)Progressive dysplasia (Cervical Intraepithelial Neoplasia – CIN)Invasion through the basement membraneThis process typically occurs over several years, providing a critical window for early detection.
6. Histological ClassificationSquamous cell carcinoma (70–80%)AdenocarcinomaAdenosquamous carcinoma
7. Clinical Presentation7.1 Early DiseaseOften asymptomaticDetected through screening7.2 Advanced DiseasePostcoital bleedingAbnormal vaginal dischargePelvic painUrinary or bowel symptoms
8. Potential ComplicationsLocal invasion of pelvic organsHemorrhageFistula formationMetastatic disease
9. Diagnostic Evaluation9.1 ScreeningPap smear (cytology)HPV DNA testing9.2 Diagnostic ProceduresColposcopy with biopsyCone biopsy for staging9.3 ImagingMRI for local stagingCT/PET for metastasis assessment
10. StagingBased on the FIGO staging system, incorporating clinical findings and imaging.
11. Comprehensive Management11.1 Early-Stage DiseaseSurgical management (conization or radical hysterectomy)Fertility-sparing procedures in selected cases11.2 Locally Advanced DiseaseConcurrent chemoradiotherapy11.3 Advanced and Metastatic DiseasePalliative chemotherapyTargeted therapy and immunotherapy (selected cases)
12. Prevention Strategies12.1 Primary PreventionHPV vaccination12.2 Secondary PreventionRegular cervical screening programs
13. Long-Term Follow-UpRegular surveillance after treatmentMonitoring for recurrencePsychosocial support
14. Frequently Asked QuestionsIs cervical cancer preventable?Yes. Vaccination and regular screening significantly reduce the risk.Can cervical cancer affect fertility?Fertility may be preserved in early-stage disease with appropriate treatment.
15. Scientific ReferencesWorld Health Organization (WHO). Cervical Cancer FactsheetAmerican Cancer Society – Cervical CancerFIGO Oncology Committee GuidelinesWilliams Gynecology, 4th Edition